Home›Stock Screener›Thyrocare Technologies

Thyrocare Technologies Share Price Today | Stock Price & Thyrocare Technologies Share Screener

THYROCARE Healthcare Services
Live Share Price NSE
₹503.60
▼ -3.35 (-0.66%)
2026-11-18 00:00:00
Live Share Price BSE
₹503.45
▼ -3.55 (-0.70%)
2026-11-18 00:00:00

As of November 18, 2026, the live Thyrocare Technologies share price (NSE: THYROCARE) is ₹503.60 on NSE and ₹503.45 on BSE, down 0.66% from the previous close, with shares trading between ₹502.95 and ₹519.85 in today's trading session, and a 52-week range of ₹349.55–₹1,535.20. Track THYROCARE market value to gauge the company's total market size. Use the Thyrocare Technologies stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Thyrocare Technologies opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹229 and net income of ₹49, with EBITDA of ₹80, an operating margin of 34.0% and a profit margin of 21.4%.

Thyrocare Technologies Market Cap ₹8,158.02 Cr.
THYROCARE P/E Ratio (TTM) 56.60
Thyrocare Technologies P/B Ratio 14.66
EPS (TTM) ₹10.27
Dividend Yield 2.75%
Debt to Equity 0.07
THYROCARE 52 Week High ₹1535.20
Thyrocare Technologies 52 Week Low ₹349.55
Operating Margin 34.00%
Profit Margin 21.40%
THYROCARE Revenue (TTM) ₹229.00
EBITDA ₹80.00
Net Income ₹49.00
Total Assets ₹747.00
Total Equity ₹586.00

Thyrocare Technologies Share Price Chart

Track the current stock price of Thyrocare Technologies with an interactive chart. Analyse THYROCARE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Thyrocare Technologies stock quote in one place.

The quote of ₹503.60 sits between the 52-week low of ₹349.55 and the 52-week high of ₹1,535.20, and the latest session moved -0.66% from the previous close.

Thyrocare Technologies Company Profile - Fundamental Screener

Screen Thyrocare Technologies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for THYROCARE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE594H01019.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE594H01019

Thyrocare Technologies Balance Sheet Screener

Screen THYROCARE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹747, up from ₹693 in 2025.

Latest statistics put total assets at ₹747 and shareholder funds at ₹586, with a leverage ratio of 0.07.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 747 693 644 633 608 546 471 475 479 438
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 317 297 306 294 285 253 269 294 299 259

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 51 24 26 20 17 23 23 19 15 12
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 586 547 528 535 527 427 367 435 443 408
Share Capital 159 53 53 53 53 53 53 53 54 54
Reserves & Surplus 354 439 440 463 474 374 314 382 390 354

Thyrocare Technologies Income Statement Screener - Profit & Revenue Analysis

Screen Thyrocare Technologies income statement and profit fundamentals. Analyze THYROCARE quarterly results. Thyrocare Technologies reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹229 and net profit was ₹49, equal to earnings per unit of ₹2.99, at an operating margin of 34%.

In that period expenses were ₹149, interest cost ₹2 and tax ₹16. The next period listed, 2026-Jun, shows revenue of ₹245 and net profit of ₹51.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 229 245 275 192 198 220 201 158 161 180 170 140 136 151 138
Expenses 149 163 227 130 135 145 144 121 115 129 124 111 100 111 103

Operating Costs and Margins

EBITDA 80 82 49 62 63 75 57 37 46 51 46 29 36 40 35
Operating Profit % 34.00% 32.00% 16.00% 30.00% 30.00% 33.00% 26.00% 22.00% 27.00% 27.00% 25.00% 18.00% 26.00% 25.00% 23.00%
Depreciation 14 13 14 14 11 12 22 13 11 13 17 11 10 11 14
Interest 2 1 2 1 1 1 0 1 1 1 1 1 1 1 1

Profit and Earnings

Profit Before Tax 64 68 34 47 51 63 35 23 34 37 28 17 25 28 20
Tax 16 17 18 26 12 15 7 6 10 10 9 5 8 8 5
Net Profit 49 51 15 22 38 48 28 17 24 26 19 13 17 20 15
EPS 2.99 3.23 0.96 4.17 7.35 9.05 1.82 3.54 4.52 4.99 3.58 2.36 3.26 3.84 2.78

Thyrocare Technologies Cash Flow Screener - Liquidity Fundamentals

Screen THYROCARE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹213, and net cash flow was an inflow of ₹21.

Over the same period, investing activities used ₹23 and financing activities used ₹170.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 213 191 168 129 113 115 168 100 107 90
Investing Activities -23 -53 -91 -39 -24 -49 1 -12 -43 -42

Financing and Net Cash

Financing Activities -170 -130 -85 -86 -89 -62 -165 -94 -64 -49
Net Cash Flow 21 8 -9 4 0 5 4 -5 0 -1

Thyrocare Technologies Shareholding Pattern Screener

See Thyrocare Technologies shareholding pattern with promoter, FII, and DII holdings. Check Thyrocare Technologies promoter holding and ownership changes for THYROCARE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 51.02%, foreign institutions 9.37%, domestic institutions 25.92% and the public 10.92%, spread across 75,186 shareholders.

The shareholder count was 75,186 in 2026-Sept, compared with 73,064 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 51.02% 60.92% 60.92% 60.93% 71.06% 71.06% 71.06% 71.06%

Institutional Investors

FII Holding 9.37% 5.44% 5.37% 4.95% 4.85% 3.23% 2.41% 2.77%
DII Holding 25.92% 20.92% 20.99% 20.51% 13.47% 14.54% 14.97% 14.67%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 10.92% 10.35% 10.18% 10.88% 8.19% 8.94% 9.21% 9.16%
Other Holding 2.77% 2.36% 2.53% 2.73% 2.43% 2.23% 2.36% 2.33%
Shareholder Count 75,186 73,064 73,377 77,969 54,142 54,566 57,403 56,666

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Thyrocare Technologies. Thyrocare Technologies dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹14.00 per unit for 2026-March, a yield of 2.75%, compared with ₹21.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹14.00, ₹21.00 and ₹18.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹14.00 2.75%
2025-March ₹21.00 6.01%
2024-March ₹18.00 7.95%
2023-March ₹18.00 9.15%
2022-March ₹15.00 10.47%
2021-March ₹25.00 9.67%
2020-March ₹5.00 1.66%
2019-March ₹20.00 12.08%
2018-March ₹10.00 5.62%
2017-March ₹10.00 5.03%

Thyrocare Technologies Stock Index Membership - Nifty & Sensex

See which indices include Thyrocare Technologies stock. Check THYROCARE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 3 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP

Thyrocare Technologies Market Events Screener - Corporate Actions

Get Thyrocare Technologies corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Thyrocare Technologies stock events that may affect THYROCARE share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 29, 2026, with a record date of October 29, 2026.

It is followed by Quarterly Result Announcement dated July 23, 2026 and Annual General Meeting dated June 30, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-29 2026-10-29 Quarterly Result Announcement NA 8.23%
2026-07-23 2026-07-23 Quarterly Result Announcement NA 5.17%
2026-06-30 2026-06-30 Annual General Meeting NA 0.58%
2026-06-23 2026-06-23 Dividend ₹ 7.00 /share 18.26%
2026-05-07 2026-05-07 Quarterly Result Announcement NA 13.28%
2026-01-28 2026-01-28 Quarterly Result Announcement NA -4.81%
2025-11-28 2025-11-28 Bonus 2:1 -5.76%
2025-10-24 2025-10-24 Dividend ₹ 7.00 /share -0.66%
2025-10-14 2025-10-14 Quarterly Result Announcement NA 7.05%
2025-07-31 2025-07-31 Annual General Meeting NA 27.09%
2025-07-25 2025-07-25 Dividend ₹ 21.00 /share 68.16%
2025-07-23 2025-07-23 Quarterly Result Announcement NA 2.06%
2025-04-23 2025-04-23 Quarterly Result Announcement NA 13.10%
2025-01-23 2025-01-23 Quarterly Result Announcement NA -2.22%
2024-10-23 2024-10-23 Quarterly Result Announcement NA 7.33%

Thyrocare Technologies Competitors Screener - Peer Stocks Comparison

Screen THYROCARE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 126,703 53.90 25,420 15.58% 2,003 64.36
Max Healthcare Institute 99,618 71.20 8,536 18.82% 1,442 73.63
Manipal Health Enterprises 93,234 104.20 10,521 25.80% 917 58.01
Aster DM Quality Care 64,303 116.10 4,769 11.25% 427 61.53
Fortis Healthcare 61,050 57.00 9,179 16.93% 1,064 56.49
Narayana Hrudayalaya 39,027 45.00 7,996 43.43% 811 60.17
Global Health 38,922 62.80 4,509 19.56% 554 63.26
Dr. Lal Path Labs 33,435 57.20 2,864 12.11% 510 57.81
Krishna Institute of Medical Sciences 31,784 163.00 3,931 28.16% 242 65.46
Syngene International 17,661 95.70 3,809 2.56% 317 66.04

Thyrocare Technologies Company Announcements - News & Reports Screener

Screen THYROCARE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 9, 2026.

The next most recent announcements are dated November 9, 2026 and November 2, 2026.

Date Update Actions
2026-11-09 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-11-09 Announcement under Regulation 30 (LODR)-Change in Management -
2026-11-02 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-10-30 Execution Of Share Purchase Agreement In Relation To The Sale Of The CompanyS Entire Shareholding In Nueclear Healthcare Limited A Wholly Owned Subsidiary Of The Company -
2026-10-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-29 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot -
2026-10-29 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-10-29 Audio Recording Of Earnings Conference Call For The Quarter And Half Year Ended September 30 2026 -
2026-10-29 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-10-29 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-29 Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026 -
2026-10-29 Board Meeting Outcome for Outcome Of The Board Meeting Held On October 29 2026 -
2026-10-22 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-22 Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026 -
2026-10-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-29 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-28 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -
2026-09-24 Grant Of Employee Stock Options Under Thyrocare Employee Stock Option Scheme. -
2026-09-24 Closure of Trading Window -
2026-09-21 Sale Of The Entire Shareholding Held By The Company In Nueclear Healthcare Limited (A Material Wholly Owned Subsidiary) Subject To The Approval Of The Shareholders Of The Company -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹503.60, within a 52-week range of ₹349.55 to ₹1,535.20. The P/E ratio is 56.60 and the P/B ratio is 14.66, with earnings per unit of ₹10.27. Market capitalisation stands at ₹8,158.02 Cr and the dividend yield is 2.75%. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.